End to End CDMO Concept Life Sciences operates across five UK sites delivering discovery chemistry through GMP manufacturing under GLP and GCP frameworks, enabling clients to run end-to-end programs with a single partner and reduced vendor management.

AI Enabled Partnerships The OpenBench integration brings AI-driven discovery to Concept Life Sciences' medicinal chemistry, in vitro screening and validation, offering accelerated timelines and opportunities to cross-sell AI-enabled discovery services to biotech and pharmaceutical customers.

Expansion Momentum 2026 expansions include expanded assay development and screening facilities and the hiring of new scientific leadership to steer integrated drug discovery, signaling growing capacity for larger programs and multi-region partnerships.

Capability Focus The company spans discovery chemistry, immunology and neuroscience, analytics, process development and GMP manufacturing, supported by in-house resources and a scientist-to-scientist culture, ideal for firms seeking seamless progression from discovery to clinic.

Market Positioning Active participation in industry events and a European expansion footprint position Concept Life Sciences to attract international clients and form multi-region collaborations, appealing to biotechs seeking speed, regulatory compliance and integrated services.